BRIEF-Bayer starts phase III trial of VEGF Trap-Eye in Asia, Russia

FRANKFURT Tue Feb 19, 2013 2:34am EST

Related Topics

FRANKFURT Feb 19 (Reuters) - Bayer AG : * Says initiated phase III trial of VEGF Trap-Eye for the treatment of diabetic

macular edema in Asia and Russia

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.